NZM2:ETR
Novozymes
55,60 €
arrow_downward
−0,36%(−0,20) 1D
1. okt., 17:30:00 GMT +2 · EUR
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za NZM2 …
Odpri
56,10 €
Visoka
56,10 €
Nizka
55,20 €
Tržna kapitalizacija
173,93 mrd.
Povprečni promet
170,00
Promet
5,00
52-tedenski najvišji tečaj
61,96 €
52-tedenski najnižji tečaj
46,74 €
Št. zaposlenih
11 tis.
Odpri
56,10 €
Visoka
56,10 €
Nizka
55,20 €
Tržna kapitalizacija
173,93 mrd.
Povprečni promet
170,00
Promet
5,00
52-tedenski najvišji tečaj
61,96 €
52-tedenski najnižji tečaj
46,74 €
Št. zaposlenih
11 tis.
Novice
Iz spletnih virov in novičarskih partnerjev
MarketBeat
·
pred 16 minutami
Insider Buying: PodcastOne (NASDAQ:PODC) Director Purchases 7,000 Shares of Company Stock
Nasdaq
·
pred 32 minutami
A Quarter of Companies Have No Analyst Coverage
MarketWatch
·
pred 21 minutami
Here’s who’s joining the S&P 500 in the index’s latest shakeup
Yahoo Finance
·
pred 2 urama
Why this analyst sees 15% upside for the S&P 500
Profil
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
Vizitka: Novozymes
Generalni direktorEster Baiget
Št. zaposlenih11,1 tis.
Ustanovljeno2000
Sedež-
SektorSpeciality chemicals
Spletno mestonovonesis.com